There is substantial evidence that oxidative injury plays a role in many types of cytotoxic insults, and that the role of free radical damage may be especially prominent in neurological disease states, such as stroke, trauma and neurodegenerative disorders such as Parkinson's disease. Recently, the applicant reported that water-soluble derivatives of C60 were highly effective neuroprotective agents capable of rescuing cortical neurons from a broad range of insults, including excitotoxicity induced by NMDA or AMPA, apoptosis produced by growth factor withdrawal or application of A-Beta (1-42), and neuronal death following oxygen-glucose deprivation. In addition, intraperitoneal administration of these compounds to a mouse model of familial ALS delayed both the onset of motor deterioration and death. Electron paramagnetic resonance spectroscopic studies confirmed that these water-soluble malonic acid derivatives of C60 retain the potent free radical scavenging capabilities of native C60 with the ability to eliminate both hydroxyl and superoxide radicals. Based on these observations, the applicants believe that neuroprotection provided by these antioxidants reflects their ability to scavenge not only hydroxyl radical but superoxide radical (O2-) at concentrations in the micromolar range. This application proposes to test the specific hypothesis that superoxide radical scavenging by C60 derivatives is a critical determinant of neuroprotective efficacy by C60 derivatives. They plan to study mechanisms of neuroprotection by generating C60 derivatives substituted with similar functional groups, but possessing differing degrees of O2- scavenging ability. The rank-order potency of derivatives will be compared for both neuroprotection and superoxide scavenging to see if these properties correlate. In addition, using Sod2mlucsf mice, which have a specific impairment in the ability to eliminate mitochondrial O2-, they will test the protective efficacy of these agents on neurons cultured from these mice, and in neonatal mice. The broader goals of this proposal are: 1) to develop these molecules as tools to study the role of O2- as both signaling molecule and neurotoxin, 2) to continue exploration of the contribution of mitochondrial O2- to neuronal cell death, 3) and to begin to define structure-function relationships for these promising compounds as a necessary step towards pre-clinical trials.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Program Officer
Jacobs, Tom P
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Washington University
Schools of Medicine
Saint Louis
United States
Zip Code
Dugan, Laura L; Tian, LinLin; Quick, Kevin L et al. (2014) Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates. Ann Neurol 76:393-402
Ali, Sameh Saad; Hardt, Joshua I; Dugan, Laura L (2008) SOD activity of carboxyfullerenes predicts their neuroprotective efficacy: a structure-activity study. Nanomedicine 4:283-94
Quick, Kevin L; Ali, Sameh S; Arch, Robert et al. (2008) A carboxyfullerene SOD mimetic improves cognition and extends the lifespan of mice. Neurobiol Aging 29:117-28
Ali, Sameh S; Hardt, Joshua I; Quick, Kevin L et al. (2004) A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties. Free Radic Biol Med 37:1191-202
Quick, K L; Hardt, J I; Dugan, L L (2000) Rapid microplate assay for superoxide scavenging efficiency. J Neurosci Methods 97:139-44
Lotharius, J; Dugan, L L; O'Malley, K L (1999) Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci 19:1284-93